A Phase I/ II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES). acbr [Internet]. 2020 Aug. 24 [cited 2026 Sep. 17];4(4):394-412. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/14778